2018-2023 Global Cystic Fibrosis (CF) Therapeutics Market Report (Status and Outlook)

Publisher Name :
Date: 11-Oct-2018
No. of pages: 136

In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Cystic Fibrosis (CF) Therapeutics market for 2018-2023.

Cystic Fibrosis is a genetic disorder that affects mostly the lungs, but also the pancreas, liver, kidneys and intestine.

CF is inherited in an autosomal recessive manner. It is caused by the presence of mutations in both copies of the gene for the cystic fibrosis transmembrane conductance regulator protein.

Over the next five years, LPI(LP Information) projects that Cystic Fibrosis (CF) Therapeutics will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares and growth opportunities of Cystic Fibrosis (CF) Therapeutics market by product type, application, key companies and key regions.

To calculate the market size, LP Information considers value generated from the sales of the following segments:

Segmentation by product type:

- CFTR Modulators

- Mucolytics

- Bronchodilators

Segmentation by application:

- Medical Application

- Others

We can also provide the customized separate regional or country-level reports, for the following regions:

- Americas

- - United States

- - Canada

- - Mexico

- - Brazil

- APAC

- - China

- - Japan

- - Korea

- - Southeast Asia

- - India

- - Australia

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Spain

- Middle East & Africa

- - Egypt

- - South Africa

- - Israel

- - Turkey

- - GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:

- AbbVie

- F. Hoffmann-La Roche

- Gilead

- Novartis

- Vertex Pharmaceuticals

- Advanced Inhalation Therapies

- Alaxia

- Teva Pharmaceutical Industries

- Merck

- Alcresta Therapeutics

- Allergan

- AstraZeneca

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

- To study and analyze the global Cystic Fibrosis (CF) Therapeutics market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.

- To understand the structure of Cystic Fibrosis (CF) Therapeutics market by identifying its various subsegments.

- Focuses on the key global Cystic Fibrosis (CF) Therapeutics players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.

- To analyze the Cystic Fibrosis (CF) Therapeutics with respect to individual growth trends, future prospects, and their contribution to the total market.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- To project the size of Cystic Fibrosis (CF) Therapeutics submarkets, with respect to key regions (along with their respective key countries).

- To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.

- To strategically profile the key players and comprehensively analyze their growth strategies.

2018-2023 Global Cystic Fibrosis (CF) Therapeutics Market Report (Status and Outlook)

Table of Contents

2018-2023 Global Cystic Fibrosis (CF) Therapeutics Market Report (Status and Outlook)

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cystic Fibrosis (CF) Therapeutics Market Size 2013-2023
2.1.2 Cystic Fibrosis (CF) Therapeutics Market Size CAGR by Region
2.2 Cystic Fibrosis (CF) Therapeutics Segment by Type
2.2.1 CFTR Modulators
2.2.2 Mucolytics
2.2.3 Pancreatic Enzyme Supplements
2.2.4 Bronchodilators
2.3 Cystic Fibrosis (CF) Therapeutics Market Size by Type
2.3.1 Global Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Type (2013-2018)
2.3.2 Global Cystic Fibrosis (CF) Therapeutics Market Size Growth Rate by Type (2013-2018)
2.4 Cystic Fibrosis (CF) Therapeutics Segment by Application
2.4.1 Medical Application
2.4.2 Others
2.5 Cystic Fibrosis (CF) Therapeutics Market Size by Application
2.5.1 Global Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Application (2013-2018)
2.5.2 Global Cystic Fibrosis (CF) Therapeutics Market Size Growth Rate by Application (2013-2018)

3 Global Cystic Fibrosis (CF) Therapeutics by Players
3.1 Global Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Players
3.1.1 Global Cystic Fibrosis (CF) Therapeutics Market Size by Players (2016-2018)
3.1.2 Global Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Players (2016-2018)
3.2 Global Cystic Fibrosis (CF) Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Cystic Fibrosis (CF) Therapeutics by Regions
4.1 Cystic Fibrosis (CF) Therapeutics Market Size by Regions
4.2 Americas Cystic Fibrosis (CF) Therapeutics Market Size Growth
4.3 APAC Cystic Fibrosis (CF) Therapeutics Market Size Growth
4.4 Europe Cystic Fibrosis (CF) Therapeutics Market Size Growth
4.5 Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size Growth

5 Americas
5.1 Americas Cystic Fibrosis (CF) Therapeutics Market Size by Countries
5.2 Americas Cystic Fibrosis (CF) Therapeutics Market Size by Type
5.3 Americas Cystic Fibrosis (CF) Therapeutics Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Cystic Fibrosis (CF) Therapeutics Market Size by Countries
6.2 APAC Cystic Fibrosis (CF) Therapeutics Market Size by Type
6.3 APAC Cystic Fibrosis (CF) Therapeutics Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Cystic Fibrosis (CF) Therapeutics by Countries
7.2 Europe Cystic Fibrosis (CF) Therapeutics Market Size by Type
7.3 Europe Cystic Fibrosis (CF) Therapeutics Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Cystic Fibrosis (CF) Therapeutics by Countries
8.2 Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size by Type
8.3 Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Cystic Fibrosis (CF) Therapeutics Market Forecast
10.1 Global Cystic Fibrosis (CF) Therapeutics Market Size Forecast (2018-2023)
10.2 Global Cystic Fibrosis (CF) Therapeutics Forecast by Regions
10.2.1 Global Cystic Fibrosis (CF) Therapeutics Forecast by Regions (2018-2023)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Cystic Fibrosis (CF) Therapeutics Forecast by Type
10.8 Global Cystic Fibrosis (CF) Therapeutics Forecast by Application

11 Key Players Analysis
11.1 AbbVie
11.1.1 Company Details
11.1.2 Cystic Fibrosis (CF) Therapeutics Product Offered
11.1.3 AbbVie Cystic Fibrosis (CF) Therapeutics Revenue, Gross Margin and Market Share (2016-2018)
11.1.4 Main Business Overview
11.1.5 AbbVie News
11.2 F. Hoffmann-La Roche
11.2.1 Company Details
11.2.2 Cystic Fibrosis (CF) Therapeutics Product Offered
11.2.3 F. Hoffmann-La Roche Cystic Fibrosis (CF) Therapeutics Revenue, Gross Margin and Market Share (2016-2018)
11.2.4 Main Business Overview
11.2.5 F. Hoffmann-La Roche News
11.3 Gilead
11.3.1 Company Details
11.3.2 Cystic Fibrosis (CF) Therapeutics Product Offered
11.3.3 Gilead Cystic Fibrosis (CF) Therapeutics Revenue, Gross Margin and Market Share (2016-2018)
11.3.4 Main Business Overview
11.3.5 Gilead News
11.4 Novartis
11.4.1 Company Details
11.4.2 Cystic Fibrosis (CF) Therapeutics Product Offered
11.4.3 Novartis Cystic Fibrosis (CF) Therapeutics Revenue, Gross Margin and Market Share (2016-2018)
11.4.4 Main Business Overview
11.4.5 Novartis News
11.5 Vertex Pharmaceuticals
11.5.1 Company Details
11.5.2 Cystic Fibrosis (CF) Therapeutics Product Offered
11.5.3 Vertex Pharmaceuticals Cystic Fibrosis (CF) Therapeutics Revenue, Gross Margin and Market Share (2016-2018)
11.5.4 Main Business Overview
11.5.5 Vertex Pharmaceuticals News
11.6 Advanced Inhalation Therapies
11.6.1 Company Details
11.6.2 Cystic Fibrosis (CF) Therapeutics Product Offered
11.6.3 Advanced Inhalation Therapies Cystic Fibrosis (CF) Therapeutics Revenue, Gross Margin and Market Share (2016-2018)
11.6.4 Main Business Overview
11.6.5 Advanced Inhalation Therapies News
11.7 Alaxia
11.7.1 Company Details
11.7.2 Cystic Fibrosis (CF) Therapeutics Product Offered
11.7.3 Alaxia Cystic Fibrosis (CF) Therapeutics Revenue, Gross Margin and Market Share (2016-2018)
11.7.4 Main Business Overview
11.7.5 Alaxia News
11.8 Teva Pharmaceutical Industries
11.8.1 Company Details
11.8.2 Cystic Fibrosis (CF) Therapeutics Product Offered
11.8.3 Teva Pharmaceutical Industries Cystic Fibrosis (CF) Therapeutics Revenue, Gross Margin and Market Share (2016-2018)
11.8.4 Main Business Overview
11.8.5 Teva Pharmaceutical Industries News
11.9 Merck
11.9.1 Company Details
11.9.2 Cystic Fibrosis (CF) Therapeutics Product Offered
11.9.3 Merck Cystic Fibrosis (CF) Therapeutics Revenue, Gross Margin and Market Share (2016-2018)
11.9.4 Main Business Overview
11.9.5 Merck News
11.10 Alcresta Therapeutics
11.10.1 Company Details
11.10.2 Cystic Fibrosis (CF) Therapeutics Product Offered
11.10.3 Alcresta Therapeutics Cystic Fibrosis (CF) Therapeutics Revenue, Gross Margin and Market Share (2016-2018)
11.10.4 Main Business Overview
11.10.5 Alcresta Therapeutics News
11.11 Allergan
11.12 AstraZeneca

12 Research Findings and Conclusion

List of Tables and Figures

Table Product Specifications of Cystic Fibrosis (CF) Therapeutics
Figure Cystic Fibrosis (CF) Therapeutics Report Years Considered
Figure Market Research Methodology
Figure Global Cystic Fibrosis (CF) Therapeutics Market Size Growth Rate 2013-2023 ($ Millions)
Table Cystic Fibrosis (CF) Therapeutics Market Size CAGR by Region 2013-2023 ($ Millions)
Table Major Players of CFTR Modulators
Table Major Players of Mucolytics
Table Major Players of Pancreatic Enzyme Supplements
Table Major Players of Bronchodilators
Table Market Size by Type (2013-2018) ($ Millions)
Table Global Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Type (2013-2018)
Figure Global Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Type (2013-2018)
Figure Global CFTR Modulators Market Size Growth Rate
Figure Global Mucolytics Market Size Growth Rate
Figure Global Pancreatic Enzyme Supplements Market Size Growth Rate
Figure Global Bronchodilators Market Size Growth Rate
Figure Cystic Fibrosis (CF) Therapeutics Consumed in Medical Application
Figure Global Cystic Fibrosis (CF) Therapeutics Market: Medical Application (2013-2018) ($ Millions)
Figure Global Medical Application YoY Growth ($ Millions)
Figure Cystic Fibrosis (CF) Therapeutics Consumed in Others
Figure Global Cystic Fibrosis (CF) Therapeutics Market: Others (2013-2018) ($ Millions)
Figure Global Others YoY Growth ($ Millions)
Table Global Cystic Fibrosis (CF) Therapeutics Market Size by Application (2013-2018) ($ Millions)
Table Global Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Application (2013-2018)
Figure Global Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Application (2013-2018)
Figure Global Cystic Fibrosis (CF) Therapeutics Market Size in Medical Application Growth Rate
Figure Global Cystic Fibrosis (CF) Therapeutics Market Size in Others Growth Rate
Table Global Cystic Fibrosis (CF) Therapeutics Revenue by Players (2016-2018) ($ Millions)
Table Global Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Players (2016-2018)
Figure Global Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Players in 2017
Table Global Cystic Fibrosis (CF) Therapeutics Key Players Head office and Products Offered
Table Cystic Fibrosis (CF) Therapeutics Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Cystic Fibrosis (CF) Therapeutics Market Size by Regions 2013-2018 ($ Millions)
Table Global Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Regions 2013-2018
Figure Global Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Regions 2013-2018
Figure Americas Cystic Fibrosis (CF) Therapeutics Market Size 2013-2018 ($ Millions)
Figure APAC Cystic Fibrosis (CF) Therapeutics Market Size 2013-2018 ($ Millions)
Figure Europe Cystic Fibrosis (CF) Therapeutics Market Size 2013-2018 ($ Millions)
Figure Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size 2013-2018 ($ Millions)
Table Americas Cystic Fibrosis (CF) Therapeutics Market Size by Countries (2013-2018) ($ Millions)
Table Americas Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Countries (2013-2018)
Figure Americas Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Countries in 2017
Table Americas Cystic Fibrosis (CF) Therapeutics Market Size by Type (2013-2018) ($ Millions)
Table Americas Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Type (2013-2018)
Figure Americas Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Type in 2017
Table Americas Cystic Fibrosis (CF) Therapeutics Market Size by Application (2013-2018) ($ Millions)
Table Americas Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Application (2013-2018)
Figure Americas Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Application in 2017
Figure United States Cystic Fibrosis (CF) Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure Canada Cystic Fibrosis (CF) Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure Mexico Cystic Fibrosis (CF) Therapeutics Market Size Growth 2013-2018 ($ Millions)
Table APAC Cystic Fibrosis (CF) Therapeutics Market Size by Countries (2013-2018) ($ Millions)
Table APAC Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Countries (2013-2018)
Figure APAC Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Countries in 2017
Table APAC Cystic Fibrosis (CF) Therapeutics Market Size by Type (2013-2018) ($ Millions)
Table APAC Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Type (2013-2018)
Figure APAC Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Type in 2017
Table APAC Cystic Fibrosis (CF) Therapeutics Market Size by Application (2013-2018) ($ Millions)
Table APAC Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Application (2013-2018)
Figure APAC Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Application in 2017
Figure China Cystic Fibrosis (CF) Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure Japan Cystic Fibrosis (CF) Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure Korea Cystic Fibrosis (CF) Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure Southeast Asia Cystic Fibrosis (CF) Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure India Cystic Fibrosis (CF) Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure Australia Cystic Fibrosis (CF) Therapeutics Market Size Growth 2013-2018 ($ Millions)
Table Europe Cystic Fibrosis (CF) Therapeutics Market Size by Countries (2013-2018) ($ Millions)
Table Europe Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Countries (2013-2018)
Figure Europe Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Countries in 2017
Table Europe Cystic Fibrosis (CF) Therapeutics Market Size by Type (2013-2018) ($ Millions)
Table Europe Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Type (2013-2018)
Figure Europe Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Type in 2017
Table Europe Cystic Fibrosis (CF) Therapeutics Market Size by Application (2013-2018) ($ Millions)
Table Europe Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Application (2013-2018)
Figure Europe Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Application in 2017
Figure Germany Cystic Fibrosis (CF) Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure France Cystic Fibrosis (CF) Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure UK Cystic Fibrosis (CF) Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure Italy Cystic Fibrosis (CF) Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure Russia Cystic Fibrosis (CF) Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure Spain Cystic Fibrosis (CF) Therapeutics Market Size Growth 2013-2018 ($ Millions)
Table Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Countries (2013-2018)
Figure Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Countries in 2017
Table Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size by Type (2013-2018) ($ Millions)
Table Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Type (2013-2018)
Figure Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Type in 2017
Table Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size by Application (2013-2018) ($ Millions)
Table Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Application (2013-2018)
Figure Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Application in 2017
Figure Egypt Cystic Fibrosis (CF) Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure South Africa Cystic Fibrosis (CF) Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure Israel Cystic Fibrosis (CF) Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure Turkey Cystic Fibrosis (CF) Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure GCC Countries Cystic Fibrosis (CF) Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure Global Cystic Fibrosis (CF) Therapeutics arket Size Forecast (2018-2023) ($ Millions)
Table Global Cystic Fibrosis (CF) Therapeutics Market Size Forecast by Regions (2018-2023) ($ Millions)
Table Global Cystic Fibrosis (CF) Therapeutics Market Size Market Share Forecast by Regions
Figure Americas Cystic Fibrosis (CF) Therapeutics Market Size 2018-2023 ($ Millions)
Figure APAC Cystic Fibrosis (CF) Therapeutics Market Size 2018-2023 ($ Millions)
Figure Europe Cystic Fibrosis (CF) Therapeutics Market Size 2018-2023 ($ Millions)
Figure Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size 2018-2023 ($ Millions)
Figure United States Cystic Fibrosis (CF) Therapeutics Market Size 2018-2023 ($ Millions)
Figure Canada Cystic Fibrosis (CF) Therapeutics Market Size 2018-2023 ($ Millions)
Figure Mexico Cystic Fibrosis (CF) Therapeutics Market Size 2018-2023 ($ Millions)
Figure Brazil Cystic Fibrosis (CF) Therapeutics Market Size 2018-2023 ($ Millions)
Figure China Cystic Fibrosis (CF) Therapeutics Market Size 2018-2023 ($ Millions)
Figure Japan Cystic Fibrosis (CF) Therapeutics Market Size 2018-2023 ($ Millions)
Figure Korea Cystic Fibrosis (CF) Therapeutics Market Size 2018-2023 ($ Millions)
Figure Southeast Asia Cystic Fibrosis (CF) Therapeutics Market Size 2018-2023 ($ Millions)
Figure India Cystic Fibrosis (CF) Therapeutics Market Size 2018-2023 ($ Millions)
Figure Australia Cystic Fibrosis (CF) Therapeutics Market Size 2018-2023 ($ Millions)
Figure Germany Cystic Fibrosis (CF) Therapeutics Market Size 2018-2023 ($ Millions)
Figure France Cystic Fibrosis (CF) Therapeutics Market Size 2018-2023 ($ Millions)
Figure UK Cystic Fibrosis (CF) Therapeutics Market Size 2018-2023 ($ Millions)
Figure Italy Cystic Fibrosis (CF) Therapeutics Market Size 2018-2023 ($ Millions)
Figure Russia Cystic Fibrosis (CF) Therapeutics Market Size 2018-2023 ($ Millions)
Figure Spain Cystic Fibrosis (CF) Therapeutics Market Size 2018-2023 ($ Millions)
Figure Egypt Cystic Fibrosis (CF) Therapeutics Market Size 2018-2023 ($ Millions)
Figure South Africa Cystic Fibrosis (CF) Therapeutics Market Size 2018-2023 ($ Millions)
Figure Israel Cystic Fibrosis (CF) Therapeutics Market Size 2018-2023 ($ Millions)
Figure Turkey Cystic Fibrosis (CF) Therapeutics Market Size 2018-2023 ($ Millions)
Figure GCC Countries Cystic Fibrosis (CF) Therapeutics Market Size 2018-2023 ($ Millions)
Table Global Cystic Fibrosis (CF) Therapeutics Market Size Forecast by Type (2018-2023) ($ Millions)
Table Global Cystic Fibrosis (CF) Therapeutics Market Size Market Share Forecast by Type (2018-2023)
Table Global Cystic Fibrosis (CF) Therapeutics Market Size Forecast by Application (2018-2023) ($ Millions)
Table Global Cystic Fibrosis (CF) Therapeutics Market Size Market Share Forecast by Application (2018-2023)
Table AbbVie Basic Information, Head Office, Major Market Areas and Its Competitors
Table AbbVie Cystic Fibrosis (CF) Therapeutics Revenue and Gross Margin (2016-2018)
Figure AbbVie Cystic Fibrosis (CF) Therapeutics Market Share (2016-2018)
Table F. Hoffmann-La Roche Basic Information, Head Office, Major Market Areas and Its Competitors
Table F. Hoffmann-La Roche Cystic Fibrosis (CF) Therapeutics Revenue and Gross Margin (2016-2018)
Figure F. Hoffmann-La Roche Cystic Fibrosis (CF) Therapeutics Market Share (2016-2018)
Table Gilead Basic Information, Head Office, Major Market Areas and Its Competitors
Table Gilead Cystic Fibrosis (CF) Therapeutics Revenue and Gross Margin (2016-2018)
Figure Gilead Cystic Fibrosis (CF) Therapeutics Market Share (2016-2018)
Table Novartis Basic Information, Head Office, Major Market Areas and Its Competitors
Table Novartis Cystic Fibrosis (CF) Therapeutics Revenue and Gross Margin (2016-2018)
Figure Novartis Cystic Fibrosis (CF) Therapeutics Market Share (2016-2018)
Table Vertex Pharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors
Table Vertex Pharmaceuticals Cystic Fibrosis (CF) Therapeutics Revenue and Gross Margin (2016-2018)
Figure Vertex Pharmaceuticals Cystic Fibrosis (CF) Therapeutics Market Share (2016-2018)
Table Advanced Inhalation Therapies Basic Information, Head Office, Major Market Areas and Its Competitors
Table Advanced Inhalation Therapies Cystic Fibrosis (CF) Therapeutics Revenue and Gross Margin (2016-2018)
Figure Advanced Inhalation Therapies Cystic Fibrosis (CF) Therapeutics Market Share (2016-2018)
Table Alaxia Basic Information, Head Office, Major Market Areas and Its Competitors
Table Alaxia Cystic Fibrosis (CF) Therapeutics Revenue and Gross Margin (2016-2018)
Figure Alaxia Cystic Fibrosis (CF) Therapeutics Market Share (2016-2018)
Table Teva Pharmaceutical Industries Basic Information, Head Office, Major Market Areas and Its Competitors
Table Teva Pharmaceutical Industries Cystic Fibrosis (CF) Therapeutics Revenue and Gross Margin (2016-2018)
Figure Teva Pharmaceutical Industries Cystic Fibrosis (CF) Therapeutics Market Share (2016-2018)
Table Merck Basic Information, Head Office, Major Market Areas and Its Competitors
Table Merck Cystic Fibrosis (CF) Therapeutics Revenue and Gross Margin (2016-2018)
Figure Merck Cystic Fibrosis (CF) Therapeutics Market Share (2016-2018)
Table Alcresta Therapeutics Basic Information, Head Office, Major Market Areas and Its Competitors
Table Alcresta Therapeutics Cystic Fibrosis (CF) Therapeutics Revenue and Gross Margin (2016-2018)
Figure Alcresta Therapeutics Cystic Fibrosis (CF) Therapeutics Market Share (2016-2018)
Table Allergan Basic Information, Head Office, Major Market Areas and Its Competitors
Table AstraZeneca Basic Information, Head Office, Major Market Areas and Its Competitors
  • Global Scalp Cooling Systems Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 16-Nov-2018        Price: US 3480 Onwards        Pages: 116
    Scalp cooling is done by applying cold temperatures to your scalp during chemotherapy treatment for cancer. Scope of the Report: Scalp cooling system works by limiting blood flow to the scalp. This can reduce the amount of the chemo treatment that reaches your head, protecting your hair follicles from the chemo drugs. The global Scalp Cooling Systems market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CA......
  • Global Schizophrenia Treatments Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 16-Nov-2018        Price: US 3480 Onwards        Pages: 121
    Schizophrenia is a mental disorder characterized by abnormal behavior and failure to understand reality. Scope of the Report: The schizophrenia treatment market is expected to witness a high growth over the forecast period owing to the increasing incidence of schizophrenia. The global Schizophrenia Treatments market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023. Th......
  • Global SDS Poly Acrylamide Gel Electrophoresis Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 16-Nov-2018        Price: US 3480 Onwards        Pages: 115
    Polyacrylamide gel electrophoresis is a technique widely used in biochemistry, forensic chemistry, genetics, molecular biology and biotechnology to separate biological macromolecules, usually proteins or nucleic acids, according to their electrophoretic mobility. Scope of the Report: Polyacrylamide gel electrophoresis is a powerful tool used to analyze RNA samples. When polyacrylamide gel is denatured after electrophoresis, it provides information on the sample composition ......
  • Global Seborrheic Dermatitis Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 16-Nov-2018        Price: US 3480 Onwards        Pages: 117
    Seborrhoeic dermatitis is a long-term skin disorder. Scope of the Report: Seborrhoeic dermatitis symptoms include red, scaly, greasy, itchy and inflamed skin. The global Seborrheic Dermatitis Treatment market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing I......
  • Global Secondary Hyperparathyroidism Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 16-Nov-2018        Price: US 3480 Onwards        Pages: 120
    Secondary hyperparathyroidism refers to the excessive secretion of parathyroid hormone by the parathyroid glands in response to hypocalcemia and associated hyperplasia of the glands. Scope of the Report: In the treatment of secondary hyperparathyroidism due to chronic kidney disease on dialysis calcimimetics do not appear to affect the risk of early death. It does decrease the need for a parathyroidectomy but caused more issues with low blood calcium levels and vomiting.......
  • Global Secure Messaging in Healthcare Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 16-Nov-2018        Price: US 3480 Onwards        Pages: 115
    Secure messaging is a server-based approach to protect sensitive data when sent beyond the corporate borders and provides compliance with industry regulations such as HIPAA, GLBA and SOX. Scope of the Report: Secure messages provide non-repudiation as the recipients are personally identified and transactions are logged by the secure email platform. The global Secure Messaging in Healthcare market is valued at xx million USD in 2017 and is expected to reach xx million......
  • Global Seizure Treatments Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 16-Nov-2018        Price: US 3480 Onwards        Pages: 116
    An epileptic seizure is a brief episode of signs or symptoms due to abnormally excessive or synchronous neuronal activity in the brain. Scope of the Report: Increasing prevalence of neurological disorders is expected to be the dominant factor driving the global seize treatment market over the forecast period. The global Seizure Treatments market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% be......
  • Global Self-Expanding Peripheral Vascular Stents Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 16-Nov-2018        Price: US 3480 Onwards        Pages: 123
    A stent is a metal or plastic tube inserted into the lumen of an anatomic vessel or duct to keep the passageway open and stenting is the placement of a stent. Scope of the Report: The high prevalence of peripheral vascular disease is expected to be drive self-expanding peripheral vascular stents market. The worldwide market for Self-Expanding Peripheral Vascular Stents is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in......
  • Global Self-Injection Delivery Systems Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 16-Nov-2018        Price: US 3480 Onwards        Pages: 118
    Self-injection systems are designed for the patient and developed with modular platform technology that enables to rapidly customize your product and aims to accelerate its time to market. Scope of the Report: Increasing demand for self-injection device is expected to drive the self-injection delivery systems market over the forecast period. The global Self-Injection Delivery Systems market is valued at xx million USD in 2017 and is expected to reach xx million USD b......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs